Literature DB >> 2786911

Biological activity of recombinant murine interleukin-6 in interleukin-1 T cell assays.

T Suda1, P Hodgkin, F Lee, A Zlotnik.   

Abstract

Interleukin-6 (also called B cell stimulatory factor 2, hepatocyte activating factor, interferon-beta 2) has been shown to have effects on various lineages of hemopoietic cells. Some of its activities appear to overlap those of interleukin-1. In particular, recombinant murine IL-6 induced proliferation of phytohemagglutinin-activated thymocytes, an assay widely used to detect IL-1. In this report, we compared several features of IL-1 and IL-6 dependent thymocyte proliferation. The results indicate that IL-2 is the major second mediator of both IL-1 and IL-6 dependent proliferation. Finally, we tested whether IL-6 would also have activity in other T cell-based IL-1 assays using the T cell lymphoma LBRM33 1A5 and the T cell clone D10-G4.1. IL-6 had no activity in the latter two assays. These results indicate that IL-1 assays using LBRM33 1A5 and D10-G4.1 selectively detect Il-1, and are more specific assays for the detection of IL-1 in samples that may also contain IL-6.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786911     DOI: 10.1016/0022-1759(89)90239-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

Review 1.  Interleukin-6 and the acute phase response.

Authors:  P C Heinrich; J V Castell; T Andus
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

2.  Substance P production by P388D1 macrophages: a possible autocrine function for this neuropeptide.

Authors:  D W Pascual; K L Bost
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

3.  Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility. Association with vascular cytokine release.

Authors:  T M McKenna
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

4.  Interleukin 1 is released by murine macrophages during apoptosis induced by Shigella flexneri.

Authors:  A Zychlinsky; C Fitting; J M Cavaillon; P J Sansonetti
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

5.  The complex pattern of cytokines in sepsis. Association between prostaglandins, cachectin, and interleukins.

Authors:  W Ertel; M H Morrison; P Wang; Z F Ba; A Ayala; I H Chaudry
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

6.  Measurement and drug induced modulation of interleukin-1 level during zymosan peritonitis in mice.

Authors:  K Török; K Németh; F Erdö; P Arányi; J I Székely
Journal:  Inflamm Res       Date:  1995-06       Impact factor: 4.575

7.  Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice.

Authors:  M Perretti; E Solito; L Parente
Journal:  Agents Actions       Date:  1992-01

8.  Expression and release of interleukin-1 by human glioblastoma cells in vitro and in vivo.

Authors:  T Gauthier; M F Hamou; L Monod; P Gallay; S Carrel; N de Tribolet
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

9.  Anti-TNF monoclonal antibodies prevent haemorrhage-induced suppression of Kupffer cell antigen presentation and MHC class II antigen expression.

Authors:  W Ertel; M H Morrison; A Ayala; M M Perrin; I H Chaudry
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.